Benitec Biopharma - ADR Financials

$12.72

$0.28 (2.25%)

As on 04-Sep-2026 16:00EDT

Market cap

$436 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

2.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Operating Revenue	0.56	--	0.22	0.08	0.07	0.06
Cost of Revenue	0.64	0.40	0.34	0.38	0.01	0.12
Gross Profit	-0.08	-0.40	-0.34	0.08	0.06	-0.06
Operating Expenses	53.82	41.77	22.49	19.16	17.92	13.53
Operating Profit (EBIT)	-53.94	-41.77	-22.49	-19.08	-17.85	-13.60
Other Income	--	--	--	--	--	--
Profit before Tax	-48.88	-37.92	-21.75	-19.56	-18.21	-13.88
Provision for Tax	--	--	-0.62	0.00	0.35	-0.10
Profit after Tax (Net Income)	-48.88	-37.92	-21.75	-19.56	-18.21	-13.88
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-19.56	-18.21	-13.88

Liabilities ($ Mln)	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Shareholder's Funds	183.33	97.30	47.25	0.20	2.88	20.01
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.39	0.50	0.04	0.28	0.56	1.09
Current Liabilities	3.27	1.80	4.92	3.98	2.53	1.37
Total Liabilities	190.27	99.59	52.21	4.46	5.97	21.38

Assets ($ Mln)	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Non-Current Assets	0.98	1.07	0.54	0.74	1.15	0.77
Current Assets	186.02	98.52	51.67	3.73	4.82	20.61
Total Assets	190.27	99.59	52.21	4.46	5.97	21.38
Total Debt*	0.88	0.85	0.28	0.56	0.81	0.21
Net Current Assets	182.74	96.72	46.75	-0.25	2.29	19.24

Cashflow ($ Mln)	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Cash From Operating Activities	--	-23.59	-19.40	-18.01	-15.90	-12.83
Cash Flow from Investing Activities	--	-0.02	-0.18	0.00	-0.01	-0.22
Cash from Financing Activities	--	70.49	68.03	16.02	16.02	22.52
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Adjusted EPS ($)	-1.16	-1.05	-2.16	-2.97	-9.47	-8.36
Cash EPS ($)	-0.93	-1.04	-2.12	-2.92	-9.27	-8.11
Adjusted Book Value ($)	5.34	2.69	4.68	0.03	1.50	12.05
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.65	-1.92	-2.74	-8.27	-7.73
Free Cash Flow per Share ($)	--	-0.65	-1.94	-2.74	-8.28	-7.86

Profitability Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
ROCE (%)	--	-52.06	-90.08	-878.40	-152.27	-89.95
ROE (%)	-35.30	-52.46	-91.68	-1,268.61	-159.08	-91.79
ROA (%)	-32.32	-49.96	-76.76	-374.86	-133.14	-83.82
EBIT Margin (%)	-9,701.08	--	-10,412.04	-25,441.33	-24,898.63	-23,518.64
Net Margin (%)	-8,792.09	--	-10,069.91	-26,082.67	-24,942.47	-23,528.81
Cash Profit Margin (%)	-0.02	--	--	--	--	--

Growth Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Revenue Growth (%)	9,366.67	-1.00	1.88	0.03	0.24	-0.39
EBIT Growth (%)	-44.20	-85.70	-17.87	-4.98	-30.99	-67.56
Net Profit Growth (%)	-44.49	-74.32	-11.19	-7.44	-31.16	-67.78
EPS Growth (%)	33.72	0.51	0.27	0.69	-0.13	0.74
Book Value Growth (%)	46.86	--	--	--	--	--

Valuation Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Price / Earnings	--	-11.17	-3.24	-0.08	-0.12	-0.51
Price / Book Value	2.31	4.35	1.49	7.77	0.77	0.35
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	850.87	-7.90	-0.90	0.02	0.06	0.93
Close Price ($)	10.65	11.70	6.99	4.05	19.72	72.25
High Price ($)	17.15	17.15	10.70	20.23	81.26	178.33
Low Price ($)	9.85	6.91	1.86	2.23	12.58	39.10
Market Cap ($ Cr)	435.61	--	--	--	--	--

Solvency Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Debt to Equity	--	0.01	0.01	2.77	0.28	0.01
Short term debt to equity ratio	0.00	0.00	0.01	1.36	0.09	0.01
Current Ratio	56.82	54.67	10.49	0.94	1.90	15.05
Quick Ratio	56.82	--	10.48	0.93	1.90	--
Interest Coverage	-13.22	-12.71	-24.88	-578.21	-568.00	-2,312.67

Operating Efficiency Ratios	TTM	Jun-25	Jun-24	Jun-23	Jun-22	Jun-21	Jun-20	Jun-19	Jun-18	Jun-17	Jun-16
Debtors to sales (%)	0.54	--	106.02	73.33	4.11	42.37
Asset Turnover	0.00	--	0.01	0.01	0.01	0.00
Receivable days	--	--	240.12	141.23	70.05	260.01
Inventory Days	--	58.11	40.47	6.23	0.08	2,815.10
Payable days	--	715.74	1,326.29	748.71	14,123.00	825.52
Cash Conversion Cycle	--	--	-1,045.71	-601.25	-14,052.87	2,249.58

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.